Diabetes

Top Story

VIDEO: Results of LEADER trial may have ‘huge impact’ on patients with diabetes

August 26, 2016

Results of the LEADER trial demonstrated that treatment with liraglutide compared with placebo in patients with type 2 diabetes not only decreased cardiovascular death, but also decreased nonfatal stroke and nonfatal myocardial infarction.

In the Journals

Psoriasis, type 2 diabetes have similar association with coronary artery calcium

August 25, 2016
Patients with psoriasis had an association with coronary artery calcium that was similar to patients with type 2 diabetes, according to recent study results published in…
In the Journals Plus

Tight glycemic control benefits questionable for microvascular, macrovascular complications

August 24, 2016
Tight glycemic control confers no substantial benefit on the risk for microvascular or macrovascular complications, despite a consistent RR reduction for nonfatal…
In the Journals

Intracoronary abciximab may improve primary PCI in patients with diabetes, STEMI

August 17, 2016
Administration of an intracoronary bolus of abciximab improved outcomes of primary PCI compared with the IV bolus in patients with diabetes and STEMI, according to a…
Meeting News Coverage

Actos reduces type 2 diabetes risk in adults with prediabetes, prior stroke

June 16, 2016
NEW ORLEANS — The risk for developing type 2 diabetes, especially among those with prediabetes and/or who have had strokes may be reduced with…

FDA News

FDA strengthens kidney warnings on Invokana, Farxiga labels

June 14, 2016
The FDA issued a drug safety communication stating that it has revised the warning labels of SGLT2 inhibitors Invokana/Invokamet and Farxiga/Xigduo…

Meeting News CoveragePerspective

Jardiance slows kidney disease progression in adults with type 2 diabetes

June 14, 2016
NEW ORLEANS — The SGLT2 inhibitor Jardiance was associated with slower progression of kidney disease and fewer clinically relevant renal events…

Meeting News Coverage

Diabetes Collaborative Registry highlights real-world clinical management of patients with diabetes

June 14, 2016
NEW ORLEANS — Clinicians who submit data to the Diabetes Collaborative Registry regularly adhere to four of seven quality metrics when treating…

Meeting News CoveragePerspective

LEADER trial: Victoza lowers risk for CV death, MI, stroke in high-risk type 2 diabetes

June 13, 2016
NEW ORLEANS — Patients with type 2 diabetes and a history of cardiovascular disease assigned Victoza therapy saw reduced risk for…

Meeting News CoveragePerspective

EXAMINE: CV events raise mortality risk for patients with diabetes

June 13, 2016
NEW ORLEANS — In patients with type 2 diabetes and a recent acute coronary syndrome in the EXAMINE trial, those who experienced nonfatal…

In the Journals

Onglyza does not increase risk for hospitalized heart failure

June 13, 2016
Recent findings published in the Annals of Internal Medicine showed that Onglyza did not increase the risk for hospitalized heart failure compared…

Meeting News Coverage

High maternal apolipoprotein B may indicate increased CV risk in children

June 12, 2016
NEW ORLEANS — Offspring of children born to mothers with elevated levels of apolipoprotein B had six times the likelihood of having high…

Meeting News Coverage

AHA metrics for heart health may translate to diabetes prevention in black adults

June 11, 2016
NEW ORLEANS — Black adults who met a higher number of the American Heart Association ideal cardiovascular health metrics also had a lower risk…

Meeting News CoveragePerspective

CVD mortality declining among U.S. adults with diabetes

June 11, 2016
NEW ORLEANS — From 2000 to 2011, adults with diabetes experienced greater reductions in cardiovascular disease mortality than adults without…

More Headlines »